ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

In Brief: Clarkson, Freireich Head AACR, ASCO; Oncology Nursing Society Membership Total Now 2,369

June 6, 1980

Study Seeks Sisters Of Women With Breast Cancer

September 27, 2002

In Brief: Mauer Resigns St. Jude Director; Breslow Named DRCCA Board Chairman; Senate Considers Line Items

August 20, 1982

In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’

July 27, 1990

IOM To Advise Army On Spending $210 Mil. Breast Cancer Money

January 8, 1993